A study of soft tissue sarcomas after childhood cancer in Britain

British Journal of Cancer

Volumn 97, Issue 5, 2007, Pages 695-699

  Jenkinson, H C ^a   Winter, D L ^b   Marsden, H B ^c   Stovall, M A ^d   Stevens, M C G ^e   Stiller, C A ^f   Hawkins, M M ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Childhood cancer; Second soft tissue sarcoma

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; ANTINEOPLASTIC ANTIBIOTIC; CYTOTOXIC AGENT; EPIPODOPHYLLOTOXIN DERIVATIVE; VINCA ALKALOID;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CHILDHOOD CANCER; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; DRUG DOSE INCREASE; DRUG EXPOSURE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; SOFT TISSUE SARCOMA;

CASE-CONTROL STUDIES; CHILD; DRUG THERAPY; GREAT BRITAIN; HUMANS; LOGISTIC MODELS; NEOPLASMS; RADIOTHERAPY; REGISTRIES; RISK FACTORS; SARCOMA;

EID: 34548319118     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603908     Document Type: Article

References (32)

1. Birch JM, Marsden HB (1987) A classification scheme for childhood cancer. Int J Cancer 40: 620-624
2. Boice JD, Blettner M, Kleinerman RA, Stovall M, Moloney WC, Engholm G, Austin DF, Bosch A, Cookfair DL, Krementz ET, Latourette HB, Peters LJ, Schulz MD, Lundell M, Pettersson F, Storm HH, Bell CMJ, Coleman MP, Fraser P, Palmer M, Prior P, Choi NW, Hislop TG, Koch M, Robb D, Robson D, Sprengler RF, von Fournier D, Frischkorn R, Lochmuller H, Pompe-Kirn V, Rimpela A, Kjorstad K, Pejovic MH, Sigurdsson K, Pisani P, Kucera H, Hutchinson GB (1987) Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst 79: 1295-1311
3. Breslow NE, Day NE (1980) Statistical Methods in Cancer Research. Volume 1: The analysis of Case - Control Studies. Lyon: International Agency for Research on Cancer
4. Breslow NE, Day NE (1987) Statistical methods in cancer research. The Design and Analysis of Cohort Studies Vol. 2. Lyon: IARC Scientific Publication
5. Breslow NE, Takashima JR, Whitton JA, Moksness J, D'Angio GJ, Green DM (1995) Second malignant neoplasms following treatment for Wilm's tumour: a report from the National Wilm's Tumour Study Group. J Clin Oncol 13: 1851-1859
6. Cellai E, Magrini SM, Masala G, Alterini R, Senioro Costantini A, Rigacci L, Olmastroni L, Papi MG, Spediacci MA, Innocenti F, Bellesi G, Rossi Ferrini P, Biti G (2001) The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital. Int J Radiat Oncol Biol Phys 49: 1327-1337
7. Draper GJ, Sanders BM, Kingston JE (1986) Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53: 661-671
8. Egret for Windows 1999 Computer Program. Massachusetts, USA: CYTEL software corporation
9. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD (1993) Mortality from second tumours among long-term survivors of retinoblastoma. J Natl Cancer Inst 85: 1121-1128
10. Hancock SL, Tucker MA, Hoppe RT (1993) Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85: 25-31
11. Hawkins MM, Draper GJ, Kingston JE (1987) Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 56: 339-347
12. Hawkins MM, Kinnier Wilson LM, Burton HS, Potok MHN, Winter DL, Marsden HB, Stovall MA (1996) Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 88: 270-278
13. Hawkins MM, Stevens MCG (1996) The long term survivors. Br Med Bull 52: 898-923
14. Hawkins MM, Swerdlow AJ (1982) Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales. Br J Cancer 66: 408-413
15. Jenkinson HC, Hawkins MM, Stiller C, Winter DL, Marsden HB, Stevens MCG (2004) Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer 91: 1905-1910
16. Kaldor JM, Day NE, Band P, Choi NW, Clarke EA, Coleman MP, Hakama M, Koch M, Langmark F, Neal FE, Pettersson F, Pompe-Kirn V, Prior P, Storm HH (1987) Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer 39: 571-585
17. Kony SJ, de Vathaire F, Chompret A, Shamsaldin A, Grimaud E, Raquin MA, Oberlin O, Brugieres L, Feunteun J, Eschwege F, Chavaudra J, Lemerle J, Bonaiti-Pellie C (1997) Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 350: 91-95
18. Le Vu B, de Vathaire F, Shamsaldin A, Hawkins MM, Grimaud E, Hardiman C, Diallo I, Vassal G, Bessa E, Campbell S, Panis X, Daly-Schveitzer N, Lagrange JL, Zucker JM, Eschwege F, Chavaudra J, Lemerle J (1998) Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer 77: 370-377
19. Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin RDT, Marsden B, Nesbit M, Newton W, Oberlin O, Sallan SG, Siegel S, Strong LC, Voute PA (1985) Second malignant neoplasms in children: an update from the late effects study group. J Clin Oncol 3: 532-538
20. Menu-Branthomme A, Rubino C, Shamsalden A, Hawkins MM, Grimaud E, Dondon M-G, Hardiman C, Vassal G, Campbell S, Panis X, Daly-Schveitzer N, Lagrange JL, Zucker JM, Chavaudra J, Hartman O, de Vathaire F (2004) Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. Int J Cancer 110: 87-93
21. Neglia J, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL (2001) Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 93: 618-629
22. Office of National Statistics. Cancer statistics - registrations in England and Wales 1971-1992, CD ROM 1999
23. Robison LL, Mertens A (1993) Second tumours after treatment of childhood malignancies. Hematol Oncol Clin North Am 7: 401-415
24. Shearer P, Kapoor G, Beckwith JB, Takashima J, Breslow N, Green DM (2001) Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: a report from the National Wilms Tumor Study Group. J Pediatr Haematol Oncol 23: 109-111
25. Stovall M, Weathers R, Kasper C, Smith SA, Travis L, Ron E, Kleinerman R (2006) Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat Res 166: 141-157
26. Toms JR (ed) (2004) Cancer Stats Monograph. London: Cancer Research UK
27. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA (1988) Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318: 76-81
28. Tucker MA, D'Angio GJ, Boice JD, Strong LC, Li FP, Stovall M, Stone BJ, Green DM, Lombardi F, Newton W, Hoover RN, Fraumeni JF (1987) Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317: 588-593
29. Westermeier T, Kaatsch P, Schoetzau A, Michaelis J (1998) Multiple primary neoplasms in childhood: data from the German children's cancer registry. Eur J Cancer 34: 687-693
30. Wong FL, Boice JD, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF, Li FP (1997) Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA 278: 1262-1267
31. World Health Organization (1976) ICD-O International Classification of Diseases for Oncology. Geneva: WHO
32. World Health Organization (1977) ICD9 International Classification of Diseases. Geneva: WHO